• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维持治疗期间低剂量17β-雌二醇——一项药代动力学和药效学研究。

Low-dose 17 beta-oestradiol during maintenance therapy--a pharmacokinetic and pharmacodynamic study.

作者信息

Nilsson K, Heimer G

机构信息

Department of Obstetrics & Gynaecology, Orebro Medical Centre Hospital, Sweden.

出版信息

Maturitas. 1995 Jan;21(1):33-8. doi: 10.1016/0378-5122(94)00865-5.

DOI:10.1016/0378-5122(94)00865-5
PMID:7731381
Abstract

The vaginal absorption of oestradiol was studied during maintenance therapy with low-dose oestradiol. Six women with severe vaginal atrophy due to oestrogen deficiency were treated with a vaginal tablet containing 25 micrograms 17 beta-oestradiol. Initially, a daily dose was given for 2 weeks, followed by maintenance therapy with twice weekly treatment for another 10 weeks. The plasma concentrations of unconjugated oestrone and oestradiol were measured before oestrogen treatment was started at the beginning of the study. After 3 months of treatment frequent plasma sampling over a period of 24 h was performed. Gonadotrophins, vaginal and urethral cytology, clinical findings and subjective symptoms were assessed at the beginning and end of the study. Plasma concentrations of unconjugated oestradiol were at all times within the limits of postmenopausal values, but showed a slight but not statistically significant elevation after 3 months compared to pretreatment values. Plasma concentrations of unconjugated oestrone were in the low postmenopausal range throughout the study. LH levels were unaffected during the study, while FSH was somewhat lowered, but still well within the postmenopausal range. Vaginal and urethral cytology showed maturation with almost complete disappearance of parabasal cells. Clinical and subjective improvement was statistically significant during the treatment period.

摘要

在低剂量雌二醇维持治疗期间研究了雌二醇的阴道吸收情况。对6名因雌激素缺乏而患有严重阴道萎缩的女性,使用含25微克17β-雌二醇的阴道片进行治疗。最初,每日给药1次,持续2周,随后进行维持治疗,每周给药2次,持续10周。在研究开始雌激素治疗前,测定未结合雌酮和雌二醇的血浆浓度。治疗3个月后,在24小时内进行多次血浆采样。在研究开始和结束时评估促性腺激素、阴道和尿道细胞学、临床发现及主观症状。未结合雌二醇的血浆浓度始终处于绝经后水平范围内,但与治疗前值相比,3个月后略有升高,但无统计学意义。在整个研究过程中,未结合雌酮的血浆浓度处于绝经后低水平范围内。在研究期间,促黄体生成素水平未受影响,而促卵泡生成素略有降低,但仍处于绝经后范围内。阴道和尿道细胞学显示细胞成熟,基底旁细胞几乎完全消失。在治疗期间,临床和主观改善具有统计学意义。

相似文献

1
Low-dose 17 beta-oestradiol during maintenance therapy--a pharmacokinetic and pharmacodynamic study.维持治疗期间低剂量17β-雌二醇——一项药代动力学和药效学研究。
Maturitas. 1995 Jan;21(1):33-8. doi: 10.1016/0378-5122(94)00865-5.
2
Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study.低剂量雌二醇治疗泌尿生殖系统雌激素缺乏症——一项药代动力学和药效学研究。
Maturitas. 1992 Oct;15(2):121-7. doi: 10.1016/0378-5122(92)90246-z.
3
Action of 25 microg 17beta-oestradiol vaginal tablets in the treatment of vaginal atrophy in Greek postmenopausal women; clinical study.
Clin Exp Obstet Gynecol. 2003;30(4):229-34.
4
Release of 17-beta-oestradiol from a vaginal ring in postmenopausal women: pharmacokinetic evaluation.绝经后女性阴道环中17-β-雌二醇的释放:药代动力学评估。
Gynecol Obstet Invest. 1994;38(4):253-60. doi: 10.1159/000292492.
5
Treatment of urogenital atrophy with low-dose estradiol: preliminary results.低剂量雌二醇治疗泌尿生殖系统萎缩:初步结果
Menopause. 2002 May-Jun;9(3):179-87. doi: 10.1097/00042192-200205000-00006.
6
Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).绝经后妇女口服及阴道给药结合马雌激素(倍美力)后血浆中雌酮、雌二醇和促性腺激素的水平
Br J Obstet Gynaecol. 1978 Dec;85(12):957-64. doi: 10.1111/j.1471-0528.1978.tb15860.x.
7
Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy.用于持续低剂量释放雌二醇以治疗泌尿生殖系统萎缩的阴道环。
Maturitas. 1989 Mar;11(1):55-63. doi: 10.1016/0378-5122(89)90120-5.
8
A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.阴道环释放的持续低剂量雌二醇与结合马雌激素阴道乳膏治疗绝经后泌尿生殖系统萎缩的安全性和有效性比较研究。
Br J Obstet Gynaecol. 1996 Apr;103(4):351-8. doi: 10.1111/j.1471-0528.1996.tb09741.x.
9
Estradiol absorption from vaginal tablets in postmenopausal women.绝经后女性阴道片的雌二醇吸收情况。
Obstet Gynecol. 2002 Apr;99(4):556-62. doi: 10.1016/s0029-7844(01)01385-0.
10
The use of local 17beta-oestradiol treatment for improving vaginal symptoms associated with post-menopausal oestrogen deficiency.使用局部17β-雌二醇治疗改善与绝经后雌激素缺乏相关的阴道症状。
J Int Med Res. 2009 Jan-Feb;37(1):198-204. doi: 10.1177/147323000903700124.

引用本文的文献

1
Hormonal replacement therapy in women with a history of internal genital organ malignancy.有内生殖器恶性肿瘤病史女性的激素替代疗法。
Prz Menopauzalny. 2021 Apr;20(1):34-39. doi: 10.5114/pm.2021.104572. Epub 2021 Mar 18.
2
Systemic estradiol levels with low-dose vaginal estrogens.全身雌二醇水平与低剂量阴道用雌激素。
Menopause. 2020 Mar;27(3):361-370. doi: 10.1097/GME.0000000000001463.
3
Should symptomatic menopausal women be offered hormone therapy?有症状的绝经后女性应该接受激素治疗吗?
MedGenMed. 2006;8(3):40.